Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...

That’s been the question floating around ResMed's (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

Koninklijke Philips N.V. (NYSE:PHG) Q4 2025 Earnings Call Transcript February 10, 2026 Koninklijke Philips N.V. beats earnings expectations. Reported EPS is $0.7, expectations were $0.504. Operator: ...

Detailed price information for Koninklijke Philips Electronics ADR (PHG-N) from The Globe and Mail including charting and trades.

Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in ...

Orders accelerated, margins expanded, and cash flow held up despite tariffs and the long shadow of Respironics.

Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that ...

Investing.com -- Koninklijke Philips NV (AS:PHG) posted a stronger fourth quarter on Tuesday, reporting a 7% rise in comparable sales and a 160-basis-point improvement in adjusted EBITA margin to ...

Amsterdam, February 10, 2026Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4Group sales of EUR 17.8 billion in ...

CHICAGO—ASSEMBLY is seeking nominations for its 2026 Assembly Plant of the Year award. The 23rd annual award will recognize a manufacturing facility in the United States that has applied world-class ...

The high flow oxygen therapy (HFOT) market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This growth is primarily driven by the ...